Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
10 min read
Adhesive capsulitis Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
5 August 2026
Explore the 2026 Adhesive capsulitis indication strategy: epidemiology, unmet need, target biology, clinical competition and deal signals using PatSnap MCP evidence.
Latest Hotspot
10 min read
Avascular necrosis of the femoral head Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
5 August 2026
2026 Avascular necrosis of the femoral head strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap.
Latest Hotspot
10 min read
Preiser disease Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
5 August 2026
Explore the 2026 Preiser disease indication strategy: epidemiology, unmet need, target biology, clinical competition and deal signals using PatSnap MCP evidence.
Latest Hotspot
10 min read
Kienbock disease Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
5 August 2026
Explore the 2026 Kienbock disease indication strategy: epidemiology, unmet need, target biology, clinical competition and deal signals using PatSnap MCP evidence.
Latest Hotspot
10 min read
Osteochondritis dissecans Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
5 August 2026
2026 Osteochondritis dissecans strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Latest Hotspot
10 min read
Osgood-Schlatter disease Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
5 August 2026
2026 Osgood-Schlatter disease strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Latest Hotspot
10 min read
Slipped capital femoral epiphysis Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
5 August 2026
2026 Slipped capital femoral epiphysis strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP.
Latest Hotspot
10 min read
Legg-Calve-Perthes disease Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
5 August 2026
2026 Legg-Calve-Perthes disease strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Latest Hotspot
10 min read
Developmental dysplasia of the hip Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
5 August 2026
2026 Developmental dysplasia of the hip strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP.
Latest Hotspot
10 min read
Clubfoot Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
5 August 2026
Explore the 2026 Clubfoot indication strategy: epidemiology, unmet need, target biology, clinical competition and deal signals using PatSnap MCP evidence.
Latest Hotspot
10 min read
Congenital vertical talus Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
5 August 2026
2026 Congenital vertical talus strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Latest Hotspot
8 min read
Morphic Therapeutic, Inc. Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
5 August 2026
Morphic Therapeutic, Inc. BD opportunity scan covering pipeline ownership, development stage, evidence package, IP risk, deal precedent and outreach rationale using PatSnap MCP.